Ser371
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser371  -  RARG (human)

Site Information
YARRRRPsQPYMFPR   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 62884000

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 , 2 ) , phospho-antibody ( 2 ) , western blotting ( 2 )
Disease tissue studied:
breast cancer ( 1 )
Relevant cell line - cell type - tissue:
HEK293T (epithelial) ( 1 ) , MCF-7 (breast cell) ( 1 ) , MEF (fibroblast) ( 2 )

Upstream Regulation
Putative in vivo kinases:
Akt1 (human) ( 1 )
Treatments:
Akt_inhibitor_VIII ( 1 )

Downstream Regulation
Effects of modification on RARG:
activity, induced ( 1 )

References 

1

Sugimoto K, et al. (2019) Cell adhesion signals regulate the nuclear receptor activity. Proc Natl Acad Sci U S A 116, 24600-24609
31740618   Curated Info

2

Chebaro Y, et al. (2017) Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptorγ. PLoS One 12, e0171043
28125680   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.